Bavarian Nordic A/S BAVA
Dividend Summary
There have not been any declared dividends recently.
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | – | – |
| Type | – | – |
| Per share | – | – |
| Declaration date | – | – |
| Ex-div date | – | – |
| Pay date | – | – |
Enter the number of Bavarian Nordic A/S shares you hold and we'll calculate your dividend payments:
Sign up for Bavarian Nordic A/S and we'll email you the dividend information when they declare.
Add Bavarian Nordic A/S to receive free notifications when they declare their dividends.
Your account is set up to receive Bavarian Nordic A/S notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| There are no Bavarian Nordic A/S dividends. | ||||||||
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0öre | — |
| 2007 | 0.0öre | 0% |
| 2008 | 0.0öre | 0% |
| 2009 | 0.0öre | 0% |
| 2010 | 0.0öre | 0% |
| 2011 | 0.0öre | 0% |
| 2012 | 0.0öre | 0% |
| 2013 | 0.0öre | 0% |
| 2014 | 0.0öre | 0% |
| 2015 | 0.0öre | 0% |
| 2016 | 0.0öre | 0% |
| 2017 | 0.0öre | 0% |
| 2018 | 0.0öre | 0% |
| 2019 | 0.0öre | 0% |
| 2020 | 0.0öre | 0% |
| 2021 | 0.0öre | 0% |
| 2022 | 0.0öre | 0% |
| 2023 | 0.0öre | 0% |
| 2024 | Sign Up Required | |
Bavarian Nordic A/S Optimized Dividend Chart
- Dividend Yield Today
- 0.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 0.0% on 26 April 2023
- 52 Week Low
- 0.0% on 26 April 2023
- Next Ex-Div-Date Countdown
- Sign Up Required
About Bavarian Nordic A/S
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate cancer, including PROSTVAC and Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) PRO; breast cancer, providing CV-301 breast and MVA-BN HER2 vaccines; and colorectal cancer, offering CV-301 colon. The Infectious Disease pipeline produces vaccines for a range of illnesses, such as smallpox, anthrax, filoviruses, foot-and-mouth diseases and respiratory syncytial virus. The Company is a parent of Bavarian Nordic GmbH, BN Infectious Diseases A/S, and Bavarian Nordic Inc, among others.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- Denmark
- Share Price
- kr.149.50 (yesterday's closing price)
- Shares in Issue
- 78 million
- Market Cap
- kr.11.7bn
- 0
- Market Indices
- none
